Lamisil

Terbinafine, the active ingredient in Lamisil, is an antifungal presented as a topical cream for skin application. It works by inhibiting fungal cell membrane synthesis and is indicated for the treatment of dermatophyte infections such as athlete’s foot, ringworm and jock itch in both adults and children.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company adheres to stringent manufacturing standards and provides reliable logistics for timely delivery.

Lamisil is used to treat fungal skin infections caused by dermatophytes.

- Athlete’s foot (tinea pedis): reduces fungal growth and clears infection of the feet. - Ringworm (tinea corporis): eliminates skin lesions and prevents spread. - Jock itch (tinea cruris): relieves itching and resolves the infection of the groin area.

Topical terbinafine may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning at the application site. - Itching or redness. - Dryness or peeling of the treated skin. - Mild rash.

Serious or Rare Side Effects: - Severe allergic reactions such as angioedema or anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity, especially with extensive use or systemic absorption. - Contact dermatitis that persists or worsens.

Before using Lamisil, consider the following precautions.

- Avoid use on broken or inflamed skin: application may increase systemic absorption. - Discontinue if signs of allergic reaction appear: seek medical attention promptly. - Consult a healthcare provider if pregnant or breastfeeding: safety has not been fully established. - Do not apply to eyes, mucous membranes, or genital areas beyond the intended region. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Terbinafine topical has limited systemic absorption, but certain interactions should be noted.

Major Interactions (Avoid): - Concurrent oral terbinafine therapy: may increase risk of hepatic toxicity.

Moderate Interactions (Monitor Closely): - Use with other topical antifungal agents: may reduce overall effectiveness. - Co‑application with corticosteroid creams: may mask local irritation. - Application over alcohol‑based skin products: may enhance absorption and irritation.